A Diagnostic and Therapeutic Scheme for a Solitary Cysticercus Granuloma
Neurol 75:2236-2245, Singh,G.,et al, 2010
Neurocysticercosis Uncovered by Single-Dose Albendazole
NEJM 356:1277-1278, Garcia,H.H.,et al, 2007
Tapeworms and Seizures--Treatment and Prevention
NEJM 350:215-217, Maguire,J.H., 2004
A Trial of Antiparasitic Treatment to Reduce the Rate of Seizures Due to Cerebral Cysticercosis
NEJM 350:249-258,215,280, Garcia,H.H.,et al, 2004
Long-term Prognosis in Patients with Vasculopathic Sixth Nerve Palsy
Am J Ophthalmol 134:81-84, Sanders,S.K.,et al, 2002
Single-Day Praziquantel Versus 1-week Albendazole for Neurocysticercosis
Neurol 52:1079-1081, DelBrutto,O.H.,et al, 1999
Large Cerebral Infarction During Praziquantel Therapy in Neurocysticercosis
Stroke 28:211-213, Bang,O.Y.,et al, 1997
Is the Course of Neurocysticercosis Modified by Treatment with Anthelmintic Agents
Arch Int Med 157:128-129, DelBrutto,O.H., 1997
Albendazole Therapy for Neurocysticercosis:A Prospective Double-Blind Trial Comparing 7 vs 14 Days of Treatment
Neurol 48:1421-1427, Garcia,H.H.,et al, 1997
Single-Day Praziquantel Therapy for Neurocysticercosis
NEJM 334:125, Corona,T.,et al, 1996
Is the Course of Neurocysticercosis Modified by Treatment with Antihelminthic Agents
Arch Int Med 155:1982-1988, Carpio,A.,et al, 1995
Medical Treatment of Cysticercosis-Ineffective
Arch Neurol 52:101-102, 1041995., Kramer,L.D., 1995
Medical Treatment of Cysticercosis-Effective
Arch Neurol 52:102-104, DelBrutto,O.H., 1995
Clinical and Immunologic Follow-up Study of Patients with Neurocysticercosis after Treatment with Praziquantel
Neurol 45:532-538, Rolfs,A.,et al, 1995
Albendazole Therapy for Persistent, Solitary Cysticercus Granulomas in Patients with Seizures
Neurol 43:1238-1240, Rajshekhar,V., 1993
The Use of Albendazole in Patients with Single Lesions Enhanced on Contrast CT
NEJM 328:356-357, DelBrutto,O.H., 1993
Albendazole Therapy for Giant Subarachnoid Cysticerci
Arch Neurol 49:535-538, DelBrutto,O.H.,et al, 1992
Therapy for Neurocysticercosis
Arch Neurol 49:290-294, Takayanagui,O.M.&Jardim,E., 1992
Total Recovery of Visual Function after Treatment for Cerebral Cysticercosis
NEJM 324:1137-1139, Santoyo,H.,et al, 1991
Treatment of Neurocysticercosis:Is Praziquantel the New Hope?
Lancet 1:262-263, Moodley,M.&Moosa,A., 1989
Drugs Five Years Later:Praziquantel
Ann Int Med 110:290-296, King,C.H.&Mahmoud,A.A.F., 1989
Neurocysticercosis:Short Course of Treatment with Albendazole
Arch Neurol 46:1231-1236, Alarcon,F.,et al, 1989
Short Course of Albendazole Therapy for Neurocysticercosis
Arch Neurol 45:1130-1133, Sotelo,J.,et al, 1988
Albendazole vs Praziquantel for Therapy for Neurocysticercosis, A Controlled Trial
Arch Neurol 45:532-534, Sotelo,J.,et al, 1988
Praziquantel in the Treatment of Neurocysticercosis:Long-Term Follow-Up
Neurol 35:752-755, Sotelo,J.,et al, 1985
A 41-Year-Old Man with Steroid-Responsive Hemiparesis
Neurol 106:e214088, Obaidi,Z.A.,et al, 2026
Reversible Leukoencephalopathy and Parkinsonism Due to CNS Involvement in Cryoglobulinemia
Neurol 106:e214622, German,A.,et al, 2026
Progressive Quadriparesis and Falls in a 66-Year-Old Man With Longstanding Human Immunodeficiency Virus
Neurol 106:e214621, Ong,B.A. & Carlson,A.K., 2026
Intravenous Thrombolysis Use in the Late Time Window Before Interhospital Transfer for Thrombectomy
JAMA Neurol 83:60-67, Seners,P.,et al, 2026
Tenecteplase for Acute Non-Large Vessel Occlusion 4.5 to 24 Hours After IschemicStroke, The OPTION Randomized Clinical Trial
JAMA doi:10.1001/JAMA.2026.0210, Ma,G.,et al, 2026
A Randomized Trial of Tenecteplase in Acute Central Retinal Artery Occlusion
NEJM 394:442-450, Ryan,S.J.,et al, 2026
Mucormycosis
NEJM 394:684-698, Kontoyiannia,D.P. & Walsh, T.J., 2026
Treatment for Brain Metastases with Stereotactic Radiation vs Hippocampal-Avoidance Whole Brain Radiation, A Randomzid Clinical Trial
JAMA doi.10.1001/JAMA.2026.0076;2026, Aizer,A.A.,et al, 2026
Secondary Prevention after Ischemic Stroke
NEJM 394:784-792, Frie,K.L.,et al, 2026
Restless Legs Syndrome, A Review
JAMA 335:703-714, Winkelmen,J.W. & Wipper, B., 2026
Zorevunersen in Children and Adolescents with Dravet Syndrome
NEJM 394:969-982, Laux,L.,et al, 2026
Niemann-Pick Type C Disease
www.UpToDate.com, Nov, Schiffmann, R., 2026
Clinical Insights Into CASPR1 and CASPR1/Contactin1 Com-lex Autoimmune Nodopathies
Neurol 106:e214403, Paramasivan,N.K.,et al, 2026
Polymyalgia Rheumatica
NEJM 394:1097-1109, Dejaco,C.,et al, 2026
Clinical Manifestations of Primary CNS T-Cell Lymphoma, Retrospective Study of Histopathologic, Molecular, and Neuroimaging Fetures
Neurol 106:e24744, Muller,K.J.,et al, 2026
A 52-Year Old Man with Acute-Onset Blindness
Neurol 106:e214827, Brown,A.M.,et al, 2026
Minimally Invasive Surgery Versus Open Craniotomy with Clot Evacuation after Intracerebral Hemorrhage
Ann Neurol 99:871-880, Murthy, S.B.,et al, 2026
Clinicopathologic Conference, Narcolepsy Type 1
NEJM 394:1530-1538, Case 2026, 2026
Asundexian for Secondary Stroke Prevention
NEJM 394:1467-1479, 1540, Sharm,M.,et al, 2026
Deep Venous Dural Arteriovenous Fistula Mimicking Progressive Dementia
Stroke 57:e180-181, Langlois-Therien,T.,et al, 2026
Status Epilepticus After Carotid Endarterectomy:An Illustrative Case of Cerebral Hyperfusion Syndrome
Stroke 57:e188-191, Reuter,P.,et al, 2026
Endovascular Venous Sinus Stenting versus CSF Shunting for Idiopathic Intracranial Hypertssion:Nationwide Real-World Outcomes
AJNR 47:1238-1243, Chen,H.,et al, 2026
Idiopathic Intracranial Hypertension Prevalence and Hormonal Contraception, A Meta-Analysis
Neurol 106:e214832, Mihalache,A.,et al, 2026
Cerebral Amyloid Angiopathy
NEJM 394:1836-1845, Greenberg,S.M., 2026